SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?


To: bob zagorin who wrote (1892)3/26/2007 11:45:07 AM
From: Steve Lokness  Respond to of 1972
 
Bob;
A Vicl partner - this seems from the outset to be rather significant to me;

biz.yahoo.com

From this press release today;
This increase in CMI (cell-mediated immune) responses translates to an apparent 50-200-fold (8 weeks and 22 weeks, respectively) increase in pDNA (plasmid DNA) vaccine potency.


Haven't checked, but must be what they are partnered over?

Good Investing!
steve